Sequence Similarity Clusters for the Entities in PDB 3HI1

Entity #1 | Chains: G,J
Glycoprotein 120 protein, length: 321 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 1 2 16711
95 % 1 2 15524 Flexibility: Medium
Max RMSD: 6.7, Avg RMSD: 4.6
PDBFlex
90 % 7 13 2744
70 % 83 166 141
50 % 83 166 166
40 % 83 166 183
30 % 83 169 205
Entity #2 | Chains: A,L
F105 Light Chain protein, length: 215 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 1 2 24684
95 % 62 88 246 Flexibility: Low
Max RMSD: 6.2, Avg RMSD: 1.9
PDBFlex
90 % 480 704 3
70 % 1634 2395 1
50 % 3317 4857 1
40 % 3764 5475 1
30 % 4665 6818 1
Entity #3 | Chains: B,H
F105 Heavy Chain protein, length: 225 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name
100 % 1 2 24665
95 % 1 2 24888
90 % 33 54 351
70 % 1602 2355 2
50 % 3318 4857 1
40 % 3765 5475 1
30 % 4666 6818 1

Instructions

In the table for each entity, view a list of similar sequences by selecting the link associated with the percentage cutoff.



View more detailed documentation on the redundancy reduction and sequence clustering procedure used by RCSB PDB.

You can also use the structure comparison tool to compare any 2 given structures


ACTION - (A) Select for download / view details OR (B) Select two chains for comparison
Rank PDB ID Entity ID Chains Description Details Taxonomy EC Number
1 4UNU 1 A, B IG LAMBDA CHAIN V-II REGION MGC LIGHT-CHAIN VARIABLE DOMAIN, RESIDUES 1-110 9606
2 3PUC 1 A Titin domain M7 (UNP RESIDUES 33774-33871) 9606 2.7.11.1 | Details
3 1U2H 1 A Aortic preferentially expressed protein 1 residues 15-113 9606
4 5IVN 1 A BC2-nanobody 30538
5 5ACM 1 A, B MCG IG LAMBDA CHAIN V-II REGION MGC 9606
6 5E7B 1 A nanobody nano-L06 9838
7 2P45 2 B ANTIBODY CAB-RN05 9838
8 2X1Q 1 A, B GELSOLIN NANOBODY 9844
9 5U64 1 B VHH-28 9838
10 6APO 1 A Anti-Marburgvirus Nucleoprotein Single Domain Antibody A 9844
11 2X1P 1 A, B, C, D GELSOLIN NANOBODY 9844
12 4B41 1 A, B ANTIBODY G7 9844
13 2JJU 1 A, B SIGNAL REGULATORY PROTEIN BETA-1 2 ISOFORMS PRODUCED BY ALTERNATIVE SPLICING. IN THIS ENTRY ISOFORM 1 (O00241-1) IS PRESENT N-TERMINAL ECTODOMAIN, RESIDUES 30-148 9606
14 4NZU 1 L 13PL heavy chain Fab 9606
15 4NZU 2 H 13PL light chain Fab 9606
16 1MJU 1 L IMMUNOGLOBULIN MS6-12 Fab fragment, LIGHT CHAIN 10090
17 1MJU 2 H IMMUNOGLOBULIN MS6-12 Fab fragment, HEAVY CHAIN 10090
18 5TZM 1 A Obscurin UNP residues 4946-5036 9606 2.7.11.1 | Details
19 5IMM 1 B Nanobody 9835
20 4QYO 1 A Fv fragment(mAb6D8) heavy chain 10090
21 4QYO 2 B Fv fragment(mAb6D8) light chain 10090
22 5NLU 1 A single domain llama antibody Nb36 9844
23 2Q20 1 A, B Vk1 O18/O8 germline light chain variable domain 9606
24 4TRP 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
25 4TRP 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
26 1MEX 1 L Fab 29G12 light chain 10090
27 1MEX 2 H Fab 29G12 heavy chain 10090
28 1MQK 1 L antibody 7E2 FV fragment, light chain 10090
29 1MQK 2 H antibody 7E2 FV fragment, heavy chain 10090
30 5IMK 1 B Nanobody 9835
31 3D9A 2 L Light Chain of HyHel10 Antibody Fragment (Fab) 10090
32 3D9A 3 H Heavy Chain of HyHel10 Antibody Fragment (Fab) 10090
33 3TPK 1 A Immunoglobulin heavy chain antibody variable domain KW1 9835
34 4BUH 1 A, B CLONE M0418 SCFV 9606
35 4B50 1 A 2H10 LLAMA VHH 9844
36 3TV3 1 L PGT128 light chain, Ig lambda-2 chain C regions PGT128 light chain 9606
37 3TV3 2 H PGT128 heavy chain, Ig gamma-1 chain C region PGT128 heavy chain 9606
38 1NCW 1 L IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, light chain 10090
39 1NCW 2 H IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, heavy chain 10090
40 2XT1 2 B CAMELID VHH 9 30538
41 5UD9 1 H Fab heavy chain 9606
42 5UD9 2 L Light chain 9606
43 4QY8 1 A Fv fragment(mAb6D8) heavy chain 10090
44 4QY8 2 B Fv fragment(mAb6D8) light chain 10090
45 4P48 1 A Antibody scFv 180 9031
46 4UDT 1 A T CELL RECEPTOR ALPHA CHAIN, T-CELL RECEPTOR ALPHA CHAIN C REGION VARIABLE DOMAIN TRAV22, RESIDUES 1-112, CONSTANT DOMAIN TRAC1, RESIDUES 2-95 9606
47 4UDT 2 B PROTEIN TRBV7-9, T-CELL RECEPTOR BETA-2 CHAIN C REGION VARIABLE DOMAIN TRBV7-9, RESIDUES 20-115, CONSTANT DOMAIN TRBC2, RESIDUES 1-129 9606
48 5TY6 1 H VRC 315 13-1b02 Fab Heavy chain 9606
49 5TY6 2 L VRC 315 13-1b02 Fab Light chain 9606
50 2XZC 1 H FAB A.17 HEAVY CHAIN 9606
51 2XZC 2 L FAB A.17 LIGHT CHAIN 9606
52 5J1S 3 C VHH domain BS-2 30538
53 2XKN 1 A, C ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT LIGHT CHAIN (IGG1), RESIDUES 1-223 10090
54 2XKN 2 B, D ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT HEAVY CHAIN (IGG1), RESIDUES 1-216 10090
55 2P49 2 B ANTIBODY CAB-RN05 TRUNCATED AT RESIDUE 121 9838
56 2I24 1 N New Antigen Receptor PBLA8 variable domain 7801
57 5L6Q 1 A, B H5AL 9606
58 5J1T 3 C VHH domain BS-2 30538
59 5KVG 2 L ZV-67 Antibody Fab Light Chain 10090
60 5KVG 3 H ZV-67 Antibody Fab Heavy Chain 10090
61 5WCA 1 H VRC315 27-1C08 Fab Heavy chain 9606
62 5WCA 2 L VRC315 27-1C08 Fab Light chain 9606
63 4XCF 1 L 4E10 Fab light chain 9606
64 4XCF 2 H 4E10 Fab heavy chain 9606
65 5M13 2 B synthetic Nanobody L2_C06 (a-MBP#2) 32630
66 5KVF 2 L ZV-64 Antibody Fab Light Chain 10090
67 5KVF 3 H ZV-64 Antibody Fab Heavy Chain 10090
68 1RUP 1 L immunoglobulin igg2a, heavy chain fab 10090
69 1RUP 2 H immunoglobulin igg2a, light chain fab 10090
70 3ESU 1 F Antibody 14b7* light chain and antibody 14b7* heavy chain linked with a synthetic (GGGGS)4 linker 10090
71 3KNB 1 A Titin titin, C-terminal domain M10, resideus 34253-34350 9606 2.7.11.1 | Details
72 3KNB 2 B Obscurin-like protein 1 obscurin-like 1, N-terminal domain, residues 1-105 9606
73 1RUK 1 L immunoglobulin igg2a, light chain fab 10090
74 1RUK 2 H immunoglobulin igg2a, heavy chain fab 10090
75 5X08 1 H Fab 4E10 Heavy chain 9606
76 5X08 2 L Fab 4E10 Light chain 9606
77 2YZ1 1 A, B Tyrosine-protein phosphatase non-receptor type substrate 1 ligand-binidng domain, Ig-like V-type domain 10090 3.5.1.2 | Details
78 2X1O 1 A, B GELSOLIN NANOBODY 9844
79 4QGY 1 A, B nanobody n25, VH domain 9844
80 5C2B 1 H scFv 3B4 heavy chain 9606
81 5C2B 2 L 3B4 light chain 9606
82 4WW1 1 A TCR Alpha Chain-TRAV21-TRAJ8 9606
83 4WW1 2 B TCR Beta Chain-TRBV7-8 9606
84 4XAW 1 L 4E10 Fab light chain 9606
85 4XAW 2 H 4E10 Fab heavy chain 9606
86 4P49 1 A Antibody scFv B8 9031
87 3N9G 1 H Fab fragment of MAb CR4354, heavy chain 9606
88 3N9G 2 L Fab fragment of MAb CR4354, light chain 9606
89 4TUL 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
90 4TUL 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
91 5DXW 1 A PD-L1 nanobody 10090
92 2NW2 1 A ELS4 TCR alpha chain 9606
93 2NW2 2 B ELS4 TCR beta chain 9606
94 5UCB 1 H Fab Heavy Chain 9606
95 5UCB 2 L Fab Light Chain 9606
96 3T0W 1 A, B immunoglobulin variable lambda domain 9606
97 2VXV 1 H HUMAN IGG ABT-325 9606
98 2VXV 2 L HUMAN IGG ABT-325 9606
99 4N9O 2 B Nanobody Nb484 Nb484 9844
100 4M3K 2 B Camelid heavy-chain antibody variable fragment cAb-H7S 9844
101 5ACL 1 A MCG IG LAMBDA CHAIN V-II REGION MGC 9606
102 3T0V 1 A immunoglobulin variable lambda domain 9606
103 4GXV 1 H, I Antibody 1F1, heavy chain 9606
104 4GXV 2 L, M Antibody 1F1, light chain 9606
105 2VXT 1 H MURINE IGG 125-2H 10090
106 2VXT 3 L MURINE IGG 125-2H 10090
107 1OAQ 1 H HEAVY CHAIN FV, RESIDUES 1-121 10090
108 1OAQ 2 L LIGHT CHAIN FV, RESIDUES 1-120 10090
109 1T2J 1 A M12-Variable Heavy domain 9606
110 1DLF 1 L ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S) FV FRAGMENT (VH AND VL DOMAINS) 10090
111 1DLF 2 H ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S) FV FRAGMENT (VH AND VL DOMAINS) 10090
112 1RUM 1 L immunoglobulin igg2a, light chain fab 10090
113 1RUM 2 H immunoglobulin igg2a, heavy chain fab 10090
114 2XA3 1 A LLAMA HEAVY CHAIN ANTIBODY D7 VARIABLE DOMAIN OF A HEAVY CHAIN ANTIBODY 9844
115 2XZA 1 H FAB A.17 HEAVY CHAIN 9606
116 2XZA 2 L FAB A.17 LIGHT CHAIN 9606
117 2WP3 1 O OBSCURIN-LIKE PROTEIN 1 IG1, RESIDUES 1-106 9606
118 2WP3 2 T TITIN M10, RESIDUES 34252-34350 9606 2.7.11.1 | Details
119 1OGA 4 D T-CELL RECEPTOR ALPHA CHAIN V REGION CONTAINS ALSO C (CONSTANT) REGION 9606
120 1OGA 5 E T-CELL RECEPTOR BETA CHAIN C REGION EXTRACELLULAR, RESIDUES 1-130 9606
121 2W60 1 A ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
122 2W60 2 B ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
123 5W24 1 L 5C4 Fab Light Chain 10090
124 5W24 2 H 5C4 Fab Heavy Chain 10090
125 4HPY 1 H CH59 Fab heavy chain 9606
126 4HPY 2 L CH59 Fab light chain 9606
127 3T65 1 B S25-2 FAB (IGG1K) heavy chain 10090
128 3T65 2 A S25-2 FAB (IGG1K) light chain 10090
129 5C6W 1 H, J Protein IGHV1-69-2,Ig lambda chain V-II region NIG-84 9606
130 1RJC 1 A camelid heavy chain antibody VHH DOMAIN, VARIABLE DOMAIN 9838
131 4JG1 1 L Fab light chain 9606
132 4JG1 2 H Fab heavy chain 9606
133 1SQ2 2 N novel antigen receptor 7801
134 3M8O 1 L IMMUNOGLOBULIN A1 LIGHT CHAIN Fab fragment 9606
135 3M8O 2 H IMMUNOGLOBULIN A1 HEAVY CHAIN Fab fragment 9606
136 4KML 2 B Nanobody 9844
137 5VF2 1 A scFv 2D10 10090
138 5I8C 1 A VRC34.01 Fab heavy chain 9606
139 5I8C 2 B VRC34.01 Fab light chain 9606
140 4O5L 1 L Fab F045-092 light chain 9606
141 4O5L 2 H Fab F045-092 heavy chain 9606
142 5MYX 1 A, C Fab c#24 light chain 10090
143 5MYX 2 B, D Fab c#24 heavy chain Pyroglutamate residue 1 (PCA) results from post-translational modification of original residue glutamine 1. 10090
144 4Z9K 2 B VHH2(F5) antibody 30538
145 3IFL 1 L 12A11 FAB antibody light chain 10090
146 3IFL 2 H 12A11 FAB antibody heavy chain 10090
147 5WK2 1 L M116 LIGHT CHAIN 9606
148 5WK2 2 H M116 HEAVY CHAIN FD 9606
149 3PP4 1 H GA101 Fab heavy chain 10090
150 3PP4 2 L GA101 Fab light chain 10090
151 3KDM 1 A, L Immunoglobulin light chain 9606
152 3KDM 2 B, H Immunoglobulin heavy chain 9606
153 5NIV 1 A Light chain of 5D3 Fab 10090
154 5NIV 2 B Heavy chain of 5D3 Fab 10090
155 5N4J 1 L LIGHT CHAIN 9606
156 5N4J 2 H HEAVY CHAIN the sequence provided include the cleavable tag 9606
157 2AJU 1 L ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
158 2AJU 2 H ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
159 2AJV 1 L Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
160 2AJV 2 H Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
161 5X4G 1 A 6H8 Fab heavy chain 10090
162 5X4G 2 B 6H8 Fab light chain 10090
163 3SY0 1 A S25-2 FAB (IGG1K) light chain 10090
164 3SY0 2 B S25-2 FAB (IGG1K) heavy chain 10090
165 1J05 1 A, L anti-CEA mAb T84.66, light chain Fv fragment 10090
166 1J05 2 B, H anti-CEA mAb T84.66, heavy chain Fv fragment 10090
167 4PTU 1 A Antibody pn132p2C05, light chain 9606
168 4PTU 2 B Antibody pn132p2C05, heavy chain 9606
169 4TPR 1 L If kappa light chain 10090
170 4TPR 2 H Fab heavy chain 10090
171 5LMW 1 A Nanobody 9844
172 4HS6 2 A, L MRCT10.v362 Fab light chain 9606
173 4HS6 3 B, H MRCT10.v362 Fab heavy chain 9606
174 3IFN 1 H 12A11 FAB antibody heavy chain 10090
175 3IFN 2 L 12A11 FAB antibody light chain 10090
176 5U3P 1 H DH511.4 Fab Heavy Chain 9606
177 5U3P 2 L DH511.4 Fab Light Chain 9606
178 5NM0 1 A, B, C, D Nb36 9844
179 4TOY 1 H 35O22 Fab Heavy chain 9606
180 4TOY 2 L 35O22 Fab Light chain 9606
181 4TUO 1 A, C Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
182 4TUO 2 B, D Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
183 3NPS 2 B S4 FAB HEAVY CHAIN 9606
184 3NPS 3 C S4 FAB LIGHT CHAIN 9606
185 2RHE 1 A BENCE-JONES PROTEIN RHE (LIGHT CHAIN) 9606
186 5I4F 1 A scFv 2D10 10090
187 1RUR 1 L immunoglobulin 13G5, light chain fab 10090
188 1RUR 2 H immunoglobulin 13G5, heavy chain fab 10090
189 4QXT 1 A Fv fragment(mAb6D8) heavy chain 10090
190 4QXT 2 B Fv fragment(mAb6D8) light chain 10090
191 5VAA 1 A, B Ig gamma-2A chain C region, A allele UNP residues 107-330 10090
192 5ADO 1 H FAB A.17 HEAVY CHAIN 9606
193 5ADO 2 L FAB A.17 LIGHT CHAIN 9606
194 4WEM 2 B Anti-F4+ETEC bacteria VHH variable region 9844
195 4XC3 1 L 4E10 Fab light chain 9606
196 4XC3 2 H 4E10 Fab heavy chain 9606
197 1X9Q 1 A 4m5.3 anti-fluorescein single chain antibody fragment antibody binding fragment 9606
198 4PPT 1 A Engineered single domain VHH antibody 9844
199 3R0M 1 A, B Llama VHH A12 9844
200 4M5Y 1 H, I Fab 5J8 heavy chain 9606
201 4M5Y 2 L, M Fab 5J8 light chain 9606
202 4TQE 1 L If kappa light chain 10090
203 4TQE 2 H Fab heavy chain 10090
204 3ZKQ 2 D XA4813 9844
205 4I13 2 B Protein ca1697 (nanobody) 9844
206 2BNU 1 A T-CELL RECEPTOR ALPHA CHAIN C REGION EXTRACELLULAR DOMAINS, RESIDUES 1-91 9606
207 2BNU 2 B T-CELL RECEPTOR BETA CHAIN C REGION EXTRACELLULAR DOMAINS, RESIDUES 1-130 9606
208 4ISV 1 A 1C2 FAB LIGHT CHAIN 10090
209 4ISV 2 B 1C2 FAB HEAVY CHAIN 10090
210 4XC1 1 L 4E10 FAB LIGHT CHAIN 9606
211 4XC1 2 H 4E10 FAB HEAVY CHAIN 9606
212 5C2U 1 B Nanobody Nanobody 9838
213 5VSI 1 H CH1/Ckappa Fab heavy chain 9606
214 5VSI 2 L CH1/Ckappa Fab light chain 9606
215 2YXM 1 A Myosin-binding protein C, slow-type I-set domain 9606
216 1XFP 1 A heavy chain antibody VHH domain 9838
217 4CMH 2 B HEAVY CHAIN OF SAR650984-FAB FRAGMENT 10090
218 4CMH 3 C LIGHT CHAIN OF SAR650984-FAB FRAGMENT 10090
219 5JXA 1 H VRC03 Heavy chain 9606
220 5JXA 2 L VRC03 Light chain 9606
221 3QHZ 1 H, I Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
222 3QHZ 2 L, M Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
223 4POY 1 A VHH-metal 9844
224 1A2Y 1 A IGG1-KAPPA D1.3 FV (LIGHT CHAIN) 10090
225 1A2Y 2 B IGG1-KAPPA D1.3 FV (HEAVY CHAIN) 10090
226 5M2W 1 A, B Llama nanobody nb8 against TssK from T6SS 9844
227 5NLW 1 A nanobody Nb36 9844
228 3CDC 1 A, B Light Chain Amyloidogenic 9606
229 3CDF 1 A, B, C, D, E, F IMMUNOGLOBULIN LIGHT CHAIN 9606
230 3UJI 1 L Light chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
231 3UJI 2 H Fab region of the heavy chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
232 3DVI 1 A Amyloidogenic light chain variable domain AL-103 9606
233 3NTC 1 L Fab light chain 10090
234 3NTC 2 H Fab heavy chain 10090
235 2DLF 1 L PROTEIN (ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S)-KAPPA (LIGHT CHAIN)) FV FRAGMENT (VL DOMAIN) SYNONYM: ANTI-DANSYL FV FRAGMENT 10090
236 2DLF 2 H PROTEIN (ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S) (HEAVY CHAIN)) FV FRAGMENT (VH DOMAIN) SYNONYM: ANTI-DANSYL FV FRAGMENT 10090
237 4YNY 1 A, C Heavy chain of antigen binding fragment, Fab 10116
238 4YNY 2 B, D Light chain of antigen binding fragment, Fab 10116
239 4TUK 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
240 4TUK 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
241 4YO0 1 A, C Heavy chain of antigen binding fragment, Fab 10116
242 4YO0 2 B, D Light chain of antigen binding fragment, Fab 10116
243 1ZVH 2 A Immunoglobulin heavy chain antibody variable domain D2-L24 9838
244 6AZM 1 A, C 580 germline antibody, light chain Fragment: Fab 9606
245 6AZM 2 B, D 580 germline antibody, heavy chain Fragment: Fab 9606
246 2X6M 1 A HEAVY CHAIN VARIABLE DOMAIN FROM DROMEDARY ENGINEERED FROM IMMUNISED DROMEDARY 9838
247 3G9A 2 B Minimizer 9838
248 4NWU 1 H APE1551 Ab Fab heavy chain 9606
249 4NWU 2 L APE1551 Ab Fab light chain 9606
250 1EEQ 1 A, B KAPPA-4 IMMUNOGLOBULIN (LIGHT CHAIN) 9606
251 1KGC 1 D T-cell receptor alpha chain 9606
252 1KGC 2 E T-cell receptor beta chain 9606
253 3HC4 1 H IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
254 3HC4 2 L IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
255 5VZR 1 A, H G4 antibody heavy chain Fab fragment 10090
256 5VZR 2 B, L G4 antibody light chain Fab fragment 10090
257 2W9D 1 H ICSM 18-ANTI-PRP THERAPEUTIC FAB HEAVY CHAIN 10090
258 2W9D 2 L ICSM 18-ANTI-PRP THERAPEUTIC FAB LIGHT CHAIN 10090
259 5EWI 1 H VRC38.01 Heavy Chain 9606
260 5EWI 2 L VRC38.01 Light Chain 9606
261 5E2W 1 L AT8 LIGHT CHAIN 10090
262 5E2W 2 H AT8 HEAVY CHAIN 10090
263 5MYK 1 A Fab c#17 light chain 10090
264 5MYK 2 B Fab c#17 heavy chain 10090
265 4NZR 1 H PGT135 heavy chain Fab 9606
266 4NZR 2 L PGT135 light chain Fab 9606
267 5MYO 1 A, C Fab c#6 light chain 10090
268 5MYO 2 B, D Fab c#6 heavy chain 10090
269 4HBC 1 H Antigen Binding Fragment, Immunoglobulin IgG - Heavy Chain 9986
270 4HBC 2 L Antigen Binding Fragment, Immunoglobulin IgG - Light Chain 9986
271 4AEH 1 H FAB ANTIBODY, HEAVY CHAIN VARIABLE DOMAIN, RESIDUES 1-231 10090
272 4AEH 2 L FAB ANTIBODY, LIGHT CHAIN VARIABLE DOMAIN, RESIDUES 1-214 10090
273 3U79 1 A, B, C, D, E, F, G, H Amyloidogenic immunoglobulin light chain protein AL-103 Y32F Y96F, variable domain 9606
274 5UEL 1 H 354NC102 Fab Heavy Chain 9606
275 5UEL 2 L 354NC102 Fab Light Chain 9606
276 3UZQ 1 A anti-dengue Mab 4E11 Single chain variable fragment 10090
277 2V17 2 H MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
278 2V17 3 L MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
279 2P43 2 B ANTIBODY CAB-RN05 9838
280 2QHL 1 A, B, C, D, E Novel immune-type receptor 10 Extracellular 7998
281 4J6R 2 H HEAVY CHAIN OF ANTIBODY VRC23 9606
282 4J6R 3 L LIGHT CHAIN OF ANTIBODY VRC23 9606
283 5E2V 1 L AT8 LIGHT CHAIN 10090
284 5E2V 2 H AT8 HEAVY CHAIN 10090
285 4KRN 1 A Nanobody/VHH domain EgA1 9844
286 5SY8 1 H 10E8 FAB HEAVY CHAIN 9606
287 5SY8 2 L 10E8 FAB LIGHT CHAIN 9606
288 4GFT 2 B Nanobody 9844
289 4TVS 2 a, b VHH Domain BS-1 30538
290 4W6Y 2 B Nanobody NbFedF9 9844
291 6EZW 1 B VHH antibody BCD090-M2 9844
292 5DD1 1 H ANTI-HIV ANTIBODY DH570 FAB HEAVY CHAIN 9544
293 5DD1 2 L ANTI-HIV ANTIBODY DH570 FAB LIGHT CHAIN 9544
294 5JUE 1 L light chain of UIC2 Fab 10090
295 5JUE 2 H heavy chain of UIC2 Fab 10090
296 5CIN 1 H FAB 4E10 HEAVY CHAIN 9606
297 5CIN 2 L FAB 4E10 LIGHT CHAIN 9606
298 1UAC 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
299 1UAC 2 H Ig VH,anti-lysozyme 10090
300 5A2J 1 H SCFV-SM3 CONTAINS BOTH H AND L CHAINS OF SCFV-SM3, CONNECTEDBY A LINKER. CHAIN L RESIDUES ARE NUMBERED FROM 1000. RESIDUES 6-115,20-129 10090
301 5JR1 1 H 10E8 heavy chain 9606
302 5JR1 2 L 10E8 mature light chain 9606
303 4HEM 2 E, F, G Anti-baseplate TP901-1 Llama vHH 02 9844
304 3CFB 1 A, L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
305 3CFB 2 B, H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
306 3WII 1 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
307 3WII 2 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
308 5OB5 2 H fAb Heavy chain 9606
309 5OB5 3 L fAb Light chain 9606
310 3BKJ 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
311 3BKJ 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
312 5I66 1 A 8B6 antibody, heavy chain 10090
313 5I66 2 B 8B6 antibody, light chain 10090
314 4JAM 1 A, H ANTIGEN BINDING FRAGMENT OF HEAVY CHAIN of CH103 9606
315 4JAM 2 B, L ANTIGEN BINDING FRAGMENT OF LIGHT CHAIN of CH103 9606
316 3QQ9 1 C, L 101F LIGHT CHAIN 10090
317 3QQ9 2 D, H 101F HEAVY CHAIN 10090
318 5FGB 1 A, B Anti-HCV E2 Fab HC84-1 light chain 9606
319 5FGB 2 C, E Anti-HCV E2 Fab HC84-1 heavy chain 9606
320 4R3S 1 A FV FRAGMENT(MAB6D8) HEAVY CHAIN 10090
321 4R3S 2 B FV FRAGMENT(MAB6D8) LIGHT CHAIN 10090
322 5W6C 1 H UCA Fab heavy chain 9606
323 5W6C 2 L UCA Fab light chain 9606
324 5M14 2 C, D synthetic Nanobody L2_G11 (a-MBP#2) 32630
325 5I1K 1 L FAB LIGHT CHAIN 9606
326 5I1K 2 H FAB HEAVY CHAIN 9606
327 3OZ9 1 L Fab NC-1 kappa light chain 10090
328 3OZ9 2 H Fab NC-1 IgG2a heavy chain 10090
329 4JDV 1 A, H Fab heavy chain NIH45-46 Germ-line HEAVY CHAIN, IG GAMMA-1 CHAIN 9606
330 4JDV 2 B, L Fab light chain NIH45-46 Germ-line Light CHAIN, IG Kappa 9606
331 5V7U 1 L CBTAU-22.1 Fab light chain 9606
332 5V7U 2 H CBTAU-22.1 Fab heavy chain 9606
333 5UEA 1 A, H Fab Heavy Chain 9606
334 5UEA 3 B, L Fab Light Chain 9606
335 4AL8 2 H FAB 2H12 HEAVY CHAIN 9606
336 4AL8 3 L FAB 2H12 LIGHT CHAIN 9606
337 1YC7 1 A, B anti-VSG immunoglobulin heavy chain variable domain cAbAn33 cAbAn33 9838
338 1EEU 1 A, B KAPPA-4 IMMUNOGLOBULIN (LIGHT CHAIN) 9606
339 3G5Y 1 A 175 light chain 10090
340 3G5Y 2 B 175 heavy chain 10090
341 5O02 2 C Nanobody (VHH) Nano-4 30538
342 4N8C 1 H, I Heavy chain of monoclonal antibody 10090
343 4N8C 2 L, M Light chain of monoclonal antibody 10090
344 5AZ2 1 H anti-human epiregulin antibody 9E5 Fab heavy chain 10090
345 5AZ2 2 L anti-human epiregulin antibody 9E5 Fab light chain 10090
346 4UNV 1 A IG LAMBDA CHAIN V-II REGION MGC LIGHT-CHAIN VARIABLE DOMAIN, RESIDUES 1-110 9606
347 4HGW 1 A Antibody Fab fragment, light chain 10090
348 4HGW 2 B Antibody Fab fragment, heavy chain 10090
349 1NLB 1 L antibody 19D9D6 light chain 10090
350 1NLB 2 H antibody 19D9D6 heavy chain 10090
351 1KXQ 2 E, F, G, H antibody VHH fragment CABAMD9 9838
352 1C5C 1 L CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 103-214) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-102) IS FROM MURINE SOURCE FAB 10090
353 1C5C 2 H CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 109-230) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-108) IS FROM MURINE SOURCE FAB 10090
354 3VFG 1 L 3F8 Light Chain 10090
355 3VFG 2 H 3F8 Heavy Chain 10090
356 4X7F 2 C, D Nano-25 Nanobody 30538
357 5TDN 1 A, C anti-HER2 Fab Light Chain 9606
358 5TDN 2 B, D anti-HER2 Fab Heavy Chain 9606
359 3QRG 1 L Fab light chain 9606
360 3QRG 2 H Fab heavy chain Fd fragment 9606
361 4UT7 1 H BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11 SCFV HEAVY CHAIN DOMAIN, RESIDUES 1-130 9606
362 4UT7 2 L BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11 SCFV LIGHT CHAIN DOMAIN, RESIDUES 1-147 9606
363 5M6A 1 A, B, C, D Bence-Jones light chain 9606
364 4LLY 2 B, D light chain Clambda 9606
365 4LGR 2 B Camelid nanobody (VHH3) 30538
366 4EBQ 1 H anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, heavy chain Fab 10090
367 4EBQ 2 L anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, light chain 10090
368 5EZI 1 H Fab c12 heavy chain 9606
369 5EZI 2 L Fab c12 Light chain 9606
370 5U66 2 A IgG1 fc derived from CD4-fc fusion 9606
371 4K23 1 H anti-uPAR antibody, heavy chain 10090
372 4K23 2 L anti-uPAR antibody, light chain 10090
373 5J57 2 B VHH single chain antibody V5E1 30538
374 3NCJ 1 L Fab15 Mut8 light chain 9606
375 3NCJ 2 H Fab15 Mut8 heavy chain 9606
376 3UO1 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
377 3UO1 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
378 4M1G 1 L Murine IgG2a A27D7 Light chain Fab domain 10090
379 4M1G 2 H Murine IgG2a A27D7 Heavy chain Fab domain 10090
380 5W05 1 L M59 FAB LIGHT CHAIN 10090
381 5W05 2 H M59 FAB HEAVY CHAIN FD 10090
382 1MFA 1 L IGG1-LAMBDA SE155-4 FAB (LIGHT CHAIN) 10090
383 1MFA 2 H IGG1-LAMBDA SE155-4 FAB (HEAVY CHAIN) 10090
384 2IPU 1 K, L IgG2a Fab fragment Heavy Chain 10090
385 2IPU 2 G, H IgG2a Fab fragment Light Chain Kappa 10090
386 5OMM 2 C Nanobody (VHH) Nano-14 30538
387 5E03 1 A mouse CTLA-4 nanobody 10090
388 3HC3 1 H IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
389 3HC3 2 L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
390 4M61 1 A, C Fab A52 light chain 10090
391 4M61 2 B, D Fab A52 heavy chain 10090
392 5LZ0 1 A, B PorM nanobody 9844
393 3BKM 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
394 3BKM 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
395 1UM5 1 L Antibody 21H3 L chain 10090
396 1UM5 2 H Antibody 21H3 H chain 10090
397 1KXV 2 C, D CAMELID VHH DOMAIN CAB10 9838
398 3QHF 1 H Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
399 3QHF 2 L Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
400 4NWT 1 L APE1531 Ab Fab light chain 9606
401 4NWT 2 H APE1531 Ab Fab heavy chain 9606
402 3WHX 1 A mAb Fab H fragment 10090
403 3WHX 2 B mAb Fab L fragment 10090
404 3NA9 1 L Fab15 light chain 9606
405 3NA9 2 H Fab15 heavy chain 9606
406 3BAE 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
407 3BAE 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
408 1NGZ 1 A Germline Metal Chelatase Catalytic Antibody, Light chain germline Fab fragment 10090
409 1NGZ 2 B Germline Metal Chelatase Catalytic Antibody, Heavy chain germline Fab fragment 10090
410 4LRI 1 A, B MSL-109 Light Chain 9606
411 4LRI 2 C, P MSL-109 Heavy Chain 9606
412 2XXC 1 B CAMELID VHH 9 30538
413 4ZTP 1 L Light chain of Fab fragment of rabbit monoclonal antibody R53 9986
414 4ZTP 2 H Heavy chain of Fab fragment of rabbit monoclonal antibody R53 9986
415 4JN2 1 A, L anti dabigatran Fab 10090
416 4JN2 2 B, H anti dabigatran Fab 10090
417 4XBE 1 L 4E10 FAB LIGHT CHAIN 9606
418 4XBE 2 H 4E10 Fab heavy chain 9606
419 1MJ8 1 L IMMUNOGLOBULIN MS6-126 Fab Fragment, LIGHT CHAIN 10090
420 1MJ8 2 H IMMUNOGLOBULIN MS6-126 Fab Fragment, HEAVY CHAIN 10090
421 3QYC 1 A, B VH domain of IgG molecule 9606
422 4EI6 1 A, C Valpha1 XV19 Type II Natural Killer T cell receptor (mouse variable domain, human constant domain) extracellular domain (SEE REMARK 999) 10090
423 4EI6 2 B, D Vbeta16 XV19 Type II Natural Killer T cell receptor (mouse variable domain, human constant domain) extracellular domain (SEE REMARK 999) 10090
424 4JFZ 1 L Fab light chain 9606
425 4JFZ 2 H Fab heavy chain 9606
426 3WIF 1 A mAb Fab H fragment 10090
427 3WIF 2 B mAb Fab L fragment 10090
428 5KVD 2 L ZV-2 Antibody Fab Light Chain 10090
429 5KVD 3 H ZV-2 Antibody Fab Heavy Chain 10090
430 3MBX 1 L X836 LIGHT CHAIN 10090
431 3MBX 2 H X836 HEAVY CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN, FD fragment 10090
432 4OF6 1 A, B Protein SYG-1, isoform b D1, UNP residues 19-129 6239
433 3TWC 1 L PGT127 light chain, Ig lambda-2 chain C regions 9606
434 3TWC 2 H PGT127 heavy chain, Ig gamma-1 chain C region 9606
435 2XXM 2 B CAMELID VHH 9 30538
436 5IR3 1 A Ig lambda chain V-VI region AR 9606
437 3QXT 1 A, B Anti-Methotrexate CDR1-3 Graft VHH 9844
438 4HHA 1 A Fab KE5 Fab fragment KE5 9606
439 4HHA 2 B Antibody KE5 AD-2S1 eptiope 9606
440 4AJ0 1 A, B, C, D GERMINAL LINE LAMBDA 3 3RCW VARIANT VARIABLE DOMAIN VARIANT OF 3RJL2, RESIDUES 1-107 9606
441 5A2K 1 H IG LAMBDA-1 CHAIN V REGION S43 RESIDUES 6-115,20-129 10090
442 4RGO 2 H 14G8 heavy chain Fab 10090
443 4RGO 3 L 14G8 light chain Fab 10090
444 5GRY 1 A, G diabody 9606
445 5UEK 2 H Fab 12E Heavy Chain 9606
446 5UEK 3 L Fab 12E Light Chain 9606
447 3NAA 1 L Fab15 Mut5 light chain 9606
448 3NAA 2 H Fab15 Mut5 heavy chain 9606
449 1Q0X 1 L Fab 9B1, light chain 10090
450 1Q0X 2 H Fab 9B1, heavy chain 10090
451 4R90 1 L Anti CD70 Llama glama Fab 27B3 Light chain 9844
452 4R90 2 H Anti CD70 Llama glama Fab 27B3 Heavy chain 9844
453 4XVT 2 H donor 45 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Heavy chain 9606
454 4XVT 3 L 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Light chain 9606
455 5JDS 1 B Nanobody 9835
456 4OB5 1 H 4E10 antibody germline precursor 7 heavy chain Fv 9606
457 4OB5 2 L 4E10 antibody germline precursor 7 light chain Fv 9606
458 5IK3 1 A, C 1E03 Fab fragment heavy chain 9606
459 5IK3 2 B, D 1E03 Fab fragment light chain 9606
460 5NPH 2 H Heavy chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
461 5NPH 3 L Light chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
462 5IHZ 1 A, C, E, H 1E01 Fab fragment heavy chain 9606
463 5IHZ 2 B, D, F, L 1E01 Fab fragment light chain 9606
464 1BWW 1 A, B PROTEIN (IG KAPPA CHAIN V-I REGION REI) IMMUNOGLOBULIN KAPPA LIGHT CHAIN 9606
465 2R1X 1 A Fab, antibody fragment (IgG1k), light chain 10090
466 2R1X 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
467 4WUK 1 H CH65 heavy chain 9606
468 4WUK 2 L CH65 light chain 9606
469 5L8L 2 B New antigen receptor variable domain 168098
470 3MLY 1 L, M Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab light chain 9606
471 3MLY 2 H, I Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab heavy chain 9606
472 5U3O 1 H DH511.2_K3 Fab Heavy Chain 9606
473 5U3O 2 L DH511.2_K3 Fab Light Chain 9606
474 1ZVY 1 A Immunoglobulin heavy chain antibody variable domain D3-L11 9838
475 5JOP 1 D, L Fab 14.22 light chain 10090
476 5JOP 2 E, H Fab14.22 heavy chain 10090
477 1U0Q 1 A, B immunoglobulin heavy chain variable domain 9844
478 4HPO 1 H CH58 Fab heavy chain 9606
479 4HPO 2 L CH58 Fab light chain 9606
480 5UKN 1 H DH522UCA Fab fragment heavy chain 9544
481 5UKN 2 L DH522UCA Fab fragment light chain 9544
482 4AIZ 1 A, C, D V2-17 PROTEIN 9606
483 4AIZ 2 B V2-17 PROTEIN 9606
484 5L21 2 B VHH-C2 30538
485 5IT2 1 H heavy chain 9606
486 5IT2 2 L light chain 9606
487 5JIH 1 A, B Ig gamma-1 chain C region Hinge-CH2-CH3, UNP Residues 108-329 9606
488 4POZ 1 C light chain of Fab fragment of 10B9 antibody 10090
489 4POZ 2 D heavy chain of Fab fragment of 10B9 antibody 10090
490 4F57 1 L Light chain of Fab of a neutralizing antibody L1 light chain of L1 9606
491 4F57 2 H Heavy chain of Fab of a neutralizing antibody L1 heavy chain of L1 9606
492 2W59 1 A, B IGY FCU3-4 9031
493 5FWO 1 A NANOBODY 9844
494 2V9T 1 A ROUNDABOUT HOMOLOG 1 IG1-2M, RESIDUES 61-166 9606
495 5KVE 2 L ZV-48 Antibody scFv Light Chain 10090
496 5KVE 3 H ZV-48 Antibody scFv Heavy chain 10090
497 1L6X 1 A IMMUNOGLOBULIN GAMMA-1 HEAVY CHAIN CONSTANT REGION Fc Fragment, Residues 119-325 9606
498 4L1H 1 A Ig kappa chain V-I region Rei 9606
499 1OL0 1 A, B IMMUNOGLOBULIN G VARIABLE HEAVY DOMAIN 9606
500 5GZ0 1 A, C FM329 light chain 1383439
501 5GZ0 2 B, D FM329 heavy chain 1383439
502 3B9V 1 A, B, C, D heavy chain variable domain 9606
503 4W2P 1 A, B, C, D Anti-Marburgvirus Nucleoprotein Single Domain Antibody C 9844
504 1VFA 1 A IGG1-KAPPA D1.3 FV (LIGHT CHAIN) 10090
505 1VFA 2 B IGG1-KAPPA D1.3 FV (HEAVY CHAIN) 10090
506 4PUB 1 H DX-2930 HEAVY CHAIN 9606
507 4PUB 2 L DX-2930 LIGHT CHAIN 9606
508 6B14 1 H Heavy chain of Fab BL3-6S97N 10090
509 6B14 2 L Light chain of Fab BL3-6S97N 10090
510 5N88 1 A, H VH59 antibody 9606
511 5DD6 1 A, H ANTI-HIV ANTIBODY DH570.mut58 FAB HEAVY CHAIN 9544
512 5DD6 2 B, L ANTI-HIV ANTIBODY DH570.mut58 FAB LIGHT CHAIN 9544
513 5TEZ 4 I TCR F50 alpha chain 9606
514 5TEZ 5 J TCR F50 beta chain 9606
515 2D7T 1 H anti polyhydroxybutyrate antibody Fv, heavy chain residues 1-133 9606
516 2D7T 2 L anti polyhydroxybutyrate antibody Fv, light chain residues 1-110 9606
517 3WIH 2 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
518 3WIH 3 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
519 5GS3 1 A, H diabody protein 9606
520 3BD3 1 A, B catalytic antibody 10090
521 4DZB 1 A Valpha7.2-Jalpha33 (MAIT T cell receptor) 9606
522 4DZB 2 B Vbeta2 (MAIT T cell receptor) 9606
523 2OTU 1 A, C, E, G Fv light chain variable domain 10090
524 2OTU 2 B, D, F, H Fv heavy chain variable domain 10090
525 3CFC 1 H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
526 3CFC 2 L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
527 6APP 1 A Anti-Marburgvirus Nucleoprotein Single Domain Antibody A 9844
528 3V4U 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
529 3V4U 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
530 2R1Y 1 A Fab, antibody fragment (IgG1k), light chain 10090
531 2R1Y 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
532 1EFQ 1 A KAPPA-4 IMMUNOGLOBULIN (LIGHT CHAIN) 9606
533 5XHG 1 A, C polypeptide(L) 562
534 5XHG 2 B, D polypeptide(H) 562
535 4XMP 2 H HEAVY CHAIN OF ANTIBODY VRC08 9606
536 4XMP 3 L LIGHT CHAIN OF ANTIBODY VRC08 9606
537 5L8J 2 B New antigen receptor variable domain 168098
538 3UYR 1 H antibody Fab heavy chain 10090
539 3UYR 2 L antibody Fab light chain 10090
540 3V0W 1 L WN1 222-5 Fab (IgG2a) light chain 10090
541 3V0W 2 H WN1 222-5 Fab (IgG2a) heavy chain 10090
542 1YQV 1 L HyHEL-5 Antibody Light Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
543 1YQV 2 H HyHEL-5 Antibody Heavy Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
544 3OAZ 1 H, M Fab 2G12, heavy chain Fab 9606
545 3OAZ 2 K, L Fab 2G12, light chain 9606
546 2R2B 1 A Fab, antibody fragment (IgG1k), light chain 10090
547 2R2B 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
548 1T6V 2 N, O novel antigen receptor 7801
549 1ZAN 1 L Fab AD11 Light Chain 10116
550 1ZAN 2 H Fab AD11 Heavy Chain 10116
551 4BSV 1 A HETERODIMERIC FC ANTIBODY AZYMETRIC VARIANT 2 IG GAMMA 1 FC DOMAIN, RESIDUES 106-330 9606
552 4BSV 2 B HETERODIMERIC FC ANTIBODY AZYMETRIC VARIANT 2 IG GAMMA 1 FC DOMAIN, RESIDUES 106-330 9606
553 4N0Y 1 H IGH526 Heavy Chain 9606
554 4N0Y 2 L IGH526 Light Chain 9606
555 3V52 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
556 3V52 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
557 3GGW 1 A, C FAB F22-4 LIGHT CHAIN 10090
558 3GGW 2 B, D FAB F22-4 HEAVY CHAIN 10090
559 2E27 1 L anti-ciguatoxin antibody, light chain Fv fragment 10090
560 2E27 2 H anti-ciguatoxin antibody, heavy chain Fv fragment 10090
561 1BEC 1 A 14.3.D T CELL ANTIGEN RECEPTOR 10090
562 1RZF 1 L Fab E51 light chain 9606
563 1RZF 2 H Fab E51 heavy chain 9606
564 4N1C 1 A, B immunoglobulin variable light chain domain 9606
565 4KTE 1 H GE148 Heavy Chain Fab Fab fragment 9544
566 4KTE 2 L GE148 Light Chain Fab 9544
567 5I8O 1 H HMM5 antibody heavy chain 9606
568 5I8O 2 L HMM5 antibody light chain 9606
569 4OUO 1 A anti Bla g 1 scFv 9031
570 4JG0 1 L Fab light chain 9606
571 4JG0 2 H Fab heavy chain 9606
572 4YGV 1 A, F aDabi-Fab2a heavy chain 9606
573 4YGV 2 B, L aDabi-Fab2a light chain 9606
574 5JDJ 1 A, B, C, D, E, F, G, H, I, J, K, L, M, N, O, P Titin 9606 2.7.11.1 | Details
575 5U4R 1 A, H VRC 315 53-1A09 Fab Heavy chain 9606
576 5U4R 2 B, L VRC 315 53-1A09 Fab Light chain 9606
577 5ALC 1 H ANTI-TICAGRELOR FAB 72, HEAVY CHAIN 9606
578 5ALC 2 L ANTI-TICAGRELOR FAB 72, LIGHT CHAIN 9606
579 3EO0 1 A, C GC-1008 Fab Light Chain 10090
580 3EO0 2 B, D GC-1008 Fab Heavy Chain 10090
581 5CIL 1 H FAB 4E10 HEAVY CHAIN 9606
582 5CIL 2 L FAB 4E10 LIGHT CHAIN 9606
583 5F3B 1 A, E RK35 Chimeric antibody heavy chain 10090
584 5F3B 2 B, F RK35 Chimeric antibody light chain 10090
585 4POU 2 B VHH Antibody 9844
586 3B5T 1 A, B, C, D, E Novel immune-type receptor 10 Extracellular fragment 7998
587 1MVF 1 A, B immunoglobulin heavy chain variable region 9838
588 4FQI 3 H antibody CR9114 heavy chain Fab 9606
589 4FQI 4 L antibody CR9114 light chain Fab Lambda 9606
590 4JVP 1 A, B Anti-HCV E2 alpaca nanobody D03 30538
591 3QSK 2 B Engineered 5 Histidine anti-RNase A Camelid VHH Antibody Domain Variant 9838
592 4AIX 1 A, B, C, D IG LAMBDA CHAIN V-IV REGION BAU 9606
593 4JHA 1 H D25 antigen-binding fragment heavy chain 9606
594 4JHA 2 L D25 light chain 9606
595 3MCL 1 L C706 MONOCLONAL LIGHT CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
596 3MCL 2 H C706 MONOCLONAL HEAVY CHAIN FD fragment of the heavy chain, CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
597 4PTT 1 A Antibody pn132p2C05, light chain 9606
598 4PTT 2 B Antibody pn132p2C05, heavy chain 9606
599 4EJ1 2 C, D Nb113 camelid antibody fragment 9844
600 5KVL 1 H Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) heavy chain Fab fragment 9606
601 5KVL 2 L Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) light chain 9606
602 5TDO 1 A, C anti-HER2 Fab Light Chain 9606
603 5TDO 2 B, D anti-HER2 Fab Heavy Chain 9606
604 2P42 2 B, D ANTIBODY CAB-RN05 9838
605 8FAB 1 A, C IGG1-LAMBDA HIL FAB (LIGHT CHAIN) 9606
606 8FAB 2 B, D IGG1-LAMBDA HIL FAB (HEAVY CHAIN) 9606
607 5NHW 1 H anti-human ActRII Bimagrumab Fab heavy-chain C-terminal FLAG-His6 tag Fab heavy-chain 9606
608 5NHW 2 L anti-human ActRII Bimagrumab Fab light-chain Fab light-chain 9606
609 5M02 3 G Protein Trav14-1,T-cell receptor alpha chain C region 10090
610 5M02 4 H T-cell receptor beta chain V region C5,T-cell receptor beta-2 chain C region 10090
611 2ZPK 1 L, M IgG1-lambda P20.1 Fab (light chain) 10090
612 2ZPK 2 H, I IgG1-lambda P20.1 Fab (heavy chain) Variable and Constant region 10090
613 4DGV 1 H HCV1 Heavy Chain Fab 9606
614 4DGV 2 L HCV1 Light Chain 9606
615 2JJV 1 A, B SIGNAL-REGULATORY PROTEIN BETA 1. 2 ISOFORMS PRODUCED BY ALTERNATIVE SPLICING. IN THIS ENTRY ISOFORM 1 (O00241-1) IS PRESENT N-TERMINAL ECTODOMAIN, RESIDUES 30-148 9606
616 2DQU 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
617 2DQU 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
618 5TH2 1 A, C cetuximab Fab, light chain 10090
619 5TH2 2 B, D cetuximab Fab, heavy chain 10090
620 4W4O 1 A, B Ig gamma-1 chain C region UNP residues 107-330 9606
621 1I8K 1 A EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY MR1SCFV LIGHT CHAIN 10090
622 1I8K 2 B EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY MR1SCFV HEAVY CHAIN 10090
623 5I8K 1 L HHH1 Fab Light chain 9606
624 5I8K 2 H HHH1 Fab Heavy chain 9606
625 4QLR 1 A, B Llama nanobody n02 VH domain 9844
626 5J56 2 B VHH single chain antibody V1C7 30538
627 4YDL 2 B, H HEAVY CHAIN OF ANTIBODY C38-VRC18.02 9606
628 4YDL 3 C, L LIGHT CHAIN OF ANTIBODY C38-VRC18.02 9606
629 3T4Y 1 A S25-2 FAB (IGG1K) LIGHT CHAIN 10090
630 3T4Y 2 B S25-2 FAB (IGG1K) HEAVY CHAIN 10090
631 1YNL 1 L Ig gamma light chain 10090
632 1YNL 2 H Ig gamma heavy chain 10090
633 5EPM 1 A, E Antibody Fab fragment heavy chain 10090
634 5EPM 2 B, F Antibody Fab fragment light chain 10090
635 2AJS 1 L Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 kappa light chain 10090
636 2AJS 2 H Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
637 5VH5 1 A Infliximab Fc 10090
638 3UMT 1 A scFv heavy chain and light chain 10090
639 3BZ4 1 A, C, E, G Fab F22-4 light chain 10090
640 3BZ4 2 B, D, F, H Fab F22-4 heavy chain 10090
641 4NUJ 1 A PGT152 light chain 9606
642 4NUJ 2 B PGT152 heavy chain 9606
643 3LIZ 2 L 4C3 monoclonal antibody Light Chain 10090
644 3LIZ 3 H 4C3 monoclonal antibody Heavy Chain 10090
645 1RUA 1 L immunoglobulin igg2a, light chain fab 10090
646 1RUA 2 H immunoglobulin igg2a, heavy chain fab 10090
647 3U2S 1 A, H PG9 heavy chain antigen-binding fragment 9606
648 3U2S 2 B, L PG9 light chain 9606
649 4X4Z 1 A, B Herceptin VL domain with F53D mutation 9606
650 3NOI 1 A, B Natural cytotoxicity triggering receptor 3 Extracellular domain (unp residues 18-130) 9606
651 5D6C 1 A, L 4497 antibody IgK (VL and CL) 9606
652 5D6C 2 B, H 4497 antibody IgG1 (VH and CH1) 9606
653 4GAG 1 H NEUTRALIZING ANTIBODY AP33 HEAVY CHAIN 10090
654 4GAG 2 L NEUTRALIZING ANTIBODY AP33 LIGHT CHAIN 10090
655 2R23 1 A Fab, antibody fragment (IgG1k), light chain 10090
656 2R23 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
657 5JII 1 A, B Ig gamma-1 chain C region Hinge-CH2-CH3, UNP Residues 108-329 9606
658 4NUG 1 L PGT151 light chain 9606
659 4NUG 2 H PGT151 heavy chain 9606
660 3IU4 1 H chP3 Fab heavy chain 10090
661 3IU4 2 L chP3 Fab light chain 10090
662 3MNZ 2 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN mouse Fv,human Fc 10090
663 3MNZ 3 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN mouse Fv,human Fc 10090
664 3MLR 1 L Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab light chain 9606
665 3MLR 2 H Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab heavy chain 9606
666 1QYG 1 L FAB M82G2, LIGHT CHAIN 10090
667 1QYG 2 H FAB M82G2, HEAVY CHAIN 10090
668 1P7K 1 A, L antibody light chain FAB 10090
669 1P7K 2 B, H antibody heavy chain FAB 10090
670 4NBX 2 B A20.1 VHH 9844
671 1G7J 1 A ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 LIGHT CHAIN 10090
672 1G7J 2 B ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 HEAVY CHAIN 10090
673 3RVV 2 C 4C1 - light chain 10090
674 3RVV 3 D 4C1 - heavy chain 10090
675 4HEP 2 G vHH17 domain 9844
676 5A2L 1 H SCFV-SM3 RESIDUES 6-115,20-129 10090
677 3P0Y 2 H Fab DL11 heavy chain 9606
678 3P0Y 3 L Fab DL11 light chain 9606
679 4NPY 1 A, L germline PGT121 light chain Fab 9606
680 4NPY 2 B, H germline PGT121 heavy chain Fab 9606
681 5IBU 1 B, L 6652 Light Chain 9606
682 5IBU 2 G, H 6652 Heavy Chain 9606
683 5VPL 2 C 4C1 - LIGHT CHAIN 10090
684 5VPL 3 D 4C1 - HEAVY CHAIN 10090
685 5WCD 1 H VRC315 04-1D02 Fab Heavy chain 9606
686 5WCD 2 L VRC315 04-1D02 Fab Light chain 9606
687 2YPV 2 H FAB 12C1 10090
688 2YPV 3 L FAB 12C1 10090
689 3QXU 1 A, B, C, D Anti-Methotrexate CDR1-3 Graft 9844
690 1PEW 1 A, B Jto2, a LAMBDA-6 TYPE IMMUNOGLOBULIN LIGHT CHAIN, VARIABLE DOMAIN IMMUNOGLOBULIN LIGHT CHAIN, VARIABLE DOMAIN 9606
691 5EDX 1 A, B CD8 alpha antigen UNP RESIDUES 2-115 9823
692 4HH9 1 A, C Fab KE5, light chain KE5 Light chain 9606
693 4HH9 2 B, D Fab KE5, heavy chain KE5 Heavy Chain 9606
694 4JY5 1 L PGT122 light chain Fab 9606
695 4JY5 2 H PGT122 heavy chain Fab 9606
696 6ELE 1 A, H fAB heavy chain 9606
697 6ELE 2 B, L fAB light chain 9606
698 2AQ2 1 A T-CELL RECEPTOR BETA CHAIN V 10090
699 1VFB 1 A IGG1-KAPPA D1.3 FV (LIGHT CHAIN) 10090
700 1VFB 2 B IGG1-KAPPA D1.3 FV (HEAVY CHAIN) 10090
701 5IML 2 B Nanobody 9835
702 5W38 1 A, B Immunoglobulin heavy constant gamma 3 Fc domain, UNP residues 155-377 9606
703 3NAC 1 L Fab15 Mut7 light chain 9606
704 3NAC 2 H Fab15 Mut7 heavy chain 9606
705 3A6C 1 L Lysozyme binding ig kappa chain V23-J2 region 10090
706 3A6C 2 H IG VH, anti-lysozyme 10090
707 2DQD 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
708 2DQD 2 H Ig VH,anti-lysozyme 10090
709 2JJS 1 A, B TYROSINE-PROTEIN PHOSPHATASE NON-RECEPTOR TYPE SUBSTRATE 1 N-TERMINAL ECTODOMAIN, RESIDUES 31-148 9606
710 1HCV 1 A IMMUNOGLOBULIN G FROM IMMUNIZED LLAMA HEAVY CHAIN VARIABLE DOMAIN FROM LLAMA 9844
711 1WTL 1 A, B BENCE-JONES PROTEIN MCG (LIGHT CHAIN) 9606
712 2I25 1 N, O New Antigen Receptor PBLA8 variable domain 7801
713 2DQT 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
714 2DQT 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
715 1Q72 1 L Fab M82G2, Light chain 10090
716 1Q72 2 H Fab M82G2, Heavy chain 10090
717 4M1D 1 L, M Fab mAb 447-52D Light Chain 9606
718 4M1D 2 H, I Fab mAb 447-52D Heavy Chain 9606
719 1SEQ 1 L Monoclonal Antibody MNAC13 FAB Light Chain 10090
720 1SEQ 2 H Monoclonal Antibody MNAC13 FAB Heavy Chain 10090
721 1G7I 1 A ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 LIGHT CHAIN 10090
722 1G7I 2 B ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 HEAVY CHAIN 10090
723 4YHO 1 H aDabi-Fab3 heavy chain 9606
724 4YHO 2 L aDabi-Fab3 light chain 9606
725 2WWK 1 O OBSCURIN-LIKE PROTEIN 1 IG1, RESIDUES 1-106 9606
726 2WWK 2 T TITIN M10, RESIDUES 34252-34350 9606 2.7.11.1 | Details
727 2R1W 1 A Fab, antibody fragment (IgG1k), light chain 10090
728 2R1W 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
729 3MO1 1 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
730 3MO1 2 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
731 4DGY 1 H HCV1 Heavy Chain Fab 9606
732 4DGY 2 L HCV1 Light Chain 9606
733 3A67 1 L Lysozyme binding ig kappa chain V23-J2 region 10090
734 3A67 2 H IG VH, anti-lysozyme 10090
735 2APB 1 A T-cell receptor beta chain V 10116
736 2APX 1 A T cell receptor beta chain V 10116
737 1RI8 1 A camelid ANTIBODY HEAVY CHAIN VHH domain, VARIABLE DOMAIN 9838
738 5EN2 1 A GD01 heavy chain 10090
739 5EN2 2 B GD01 light chain 10090
740 3T77 1 A S25-2 FAB (IGG1K) light chain 10090
741 3T77 2 B S25-2 FAB (IGG1K) heavy chain 10090
742 1J1X 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
743 1J1X 2 H Ig VH,anti-lysozyme 10090
744 5L8K 2 B New antigen receptor variable domain 168098
745 5M2J 2 D Anti-(ED-B) scFV 9606
746 3MXW 2 L 5E1 light chain 9606
747 3MXW 3 H 5E1 heavy chain 9606
748 2V7N 1 A, C, E, G IMMUNOGLOBULIN LIGHT CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-255 32630
749 2V7N 2 B, D, F, H IMMUNOGLOBULIN HEAVY CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-259 32630
750 2DQC 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
751 2DQC 2 H Ig VH,anti-lysozyme 10090
752 1J1O 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
753 1J1O 2 H Ig VH,anti-lysozyme 10090
754 1TVD 1 A, B T CELL RECEPTOR DELTA CHAIN, VARIABLE DOMAIN 9606
755 3EO9 1 L Efalizumab Fab fragment, light chain 9606
756 3EO9 2 H Efalizumab Fab fragment, heavy chain 9606
757 1MVU 1 A Ig kappa-chain VJ-region (Light chain) LIGHT AND HEAVY CHAINS LINKED WITH A SYNTHETIC (GGGGS)3 LINKER 10090
758 1MVU 2 B Ig VDJ-region (HEAVY CHAIN) LIGHT AND HEAVY CHAINS LINKED WITH A SYNTHETIC (GGGGS)3 LINKER 10090
759 4M62 1 L, M GEP2 FV light chain UNP residues 21-129 9606
760 4M62 2 H, I GEP2 FV heavy chain 9606
761 4ALA 2 H FAB 2H12 HEAVY CHAIN 10090
762 4ALA 3 L FAB 2H12 LIGHT CHAIN 10090
763 5IVO 1 A BC2-nanobody 30538
764 1J1P 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
765 1J1P 2 H Ig VH,anti-lysozyme 10090
766 4F33 1 A, C, E, G MORAb-009 FAB light chain 10090
767 4F33 2 B, D, F, H MORAb-009 FAB heavy chain 10090
768 4NBZ 2 B, D A26.8 VHH 9844
769 3C6S 1 A, C, E, G Fab F22-4 light chain 10090
770 3C6S 2 B, D, F, H Fab F22-4 heavy chain 10090
771 5WUV 1 L light chain 9606
772 5WUV 2 H heavy chain 9606
773 1QAC 1 A, B IMMUNOGLOBULIN LIGHT CHAIN VARIABLE DOMAIN VARIABLE DOMAIN 9606
774 4Z8F 1 H S1-15 Fab (IgG2b) heavy chain 10090
775 4Z8F 2 L S1-15 Fab (IgG2b kappa) light chain 10090
776 3OKL 1 A S25-39 Fab (IgG1k) light chain 10090
777 3OKL 2 B S25-39 Fab (IgG1k) heavy chain 10090
778 2BNQ 4 D T-CELL RECEPTOR ALPHA CHAIN V REGION CONTAINS ALSO C (CONSTANT) REGION 9606
779 2BNQ 5 E T-CELL RECEPTOR BETA CHAIN C REGION EXTRACELLULAR, RESIDUES 1-130 9606
780 5AYU 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
781 5AYU 2 H Ig VH,anti-lysozyme 10090
782 4JM4 1 H PGT 135 Heavy Chain Fab 9606
783 4JM4 2 L PGT 135 Light Chain Fab 9606
784 2HWZ 1 L Immunoglobulin Fab light chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
785 2HWZ 2 H Immunoglobulin Fab heavy chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
786 3A6B 1 L Lysozyme binding ig kappa chain V23-J2 region 10090
787 3A6B 2 H IG VH, anti-lysozyme 10090
788 2DQJ 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
789 2DQJ 2 H Ig VH,anti-lysozyme 10090
790 5F21 2 B nanobody MU375 9844
791 1N4X 1 L, M immunoglobulin kappa chain variable region 10090
792 1N4X 2 H, I immunoglobulin heavy chain variable region 10090
793 6B0G 1 C 1245 Antibody, Light Chain 9606
794 6B0G 2 D 1245 Antibody, Heavy Chain 9606
795 5TDP 1 A, C anti-HER2 Fab Light Chain 9606
796 5TDP 2 B, D anti-HER2 Fab Heavy Chain 9606
797 1ZEA 1 L monoclonal anti-cholera toxin IGG1 KAPPA antibody, L chain 10090
798 1ZEA 2 H monoclonal anti-cholera toxin IGG1 KAPPA antibody, H chain 10090
799 4WNQ 1 A, C TCR Variable Delta 1 chain and TCR constant Alpha chain 9606
800 4WNQ 2 B, D TCR Variable Beta 2 (TRBV20) chain and TCR constant Beta chain 9606
801 2Q86 1 A, C Valpha14 TCR extracellular domain 10090
802 2Q86 2 B, D Vbeta8.2 extracellular domain 10090
803 2P44 2 B ANTIBODY CAB-RN05 9838
804 3DVF 1 A Amyloidogenic immunoglobulin light chain protein AL-12 9606
805 5TPP 1 L DH270.5 Fab heavy chain 9606
806 5TPP 2 H DH270.5 Fab light chain 9606
807 5L88 1 H Anti-afamin antibody N14, Fab fragment, heavy chain 10090
808 5L88 2 L Anti-afamin antibody N14, Fab fragment, light chain 10090
809 1KIQ 1 A MONOCLONAL ANTIBODY D1.3 10090
810 1KIQ 2 B MONOCLONAL ANTIBODY D1.3 10090
811 1Q9W 1 A, C S45-18 Fab (IgG1k) light chain Fab1 Light chain kappa 10090
812 1Q9W 2 B, D S45-18 Fab (IgG1k) heavy chain Fab1 Heavy chain g1 10090
813 4P3C 1 H Heavy Chain Fab fragment of antibody LEM-2/15 MT1-MMP V-B loop 10090
814 4P3C 2 L Light Chain Fab fragment of antibody LEM-2/15 10090
815 5TP3 1 A, B F-VHH-4 9844
816 5D7K 1 D MAV36 TCR Alpha Chain 9606
817 5D7K 2 E MAV36 TCR Beta Chain 9606
818 2IMN 1 A IGA-KAPPA MCPC603 FV (LIGHT CHAIN) 10090
819 1L7I 1 L chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence light chain (residues 1-214) 9606
820 1L7I 2 H chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence heavy chain (residues 1-216) 9606
821 1JPT 1 L immunoglobulin Fab D3h44, light chain Fab fragment 9606
822 1JPT 2 H immunoglobulin Fab D3H44, heavy chain Fab fragment 9606
823 1AQK 1 L FAB B7-15A2 IMMUNOGLOBULIN HUMAN FAB FAB 9606
824 1AQK 2 H FAB B7-15A2 IMMUNOGLOBULIN HUMAN FAB FAB 9606
825 3B5G 1 A, B AMYLOID LAMBDA 6 LIGHT CHAIN VARIABLE REGION PIP residues 1-111 9606
826 5TL5 1 L M2177 LIGHT CHAIN 10090
827 5TL5 2 H M2177 HEAVY CHAIN 10090
828 2JJW 1 A SIGNAL REGULATORY PROTEIN GAMMA ISOFORM 4 N-TERMINAL ECTODOMAIN, RESIDUES 29-147 9606
829 2FX7 1 L Fab 4E10 Light Chain 9606
830 2FX7 2 H Fab 4E10 Heavy Chain 9606
831 5W5N 1 A, B Immunoglobulin heavy constant gamma 4 Sigma2 Fc fragment, UNP residues 106-327 9606
832 4DTG 1 L Humanized recombinant FAB fragment, FAB 2021, of a murine antibody, light chain 9606
833 4DTG 2 H Humanized recombinant FAB fragment, FAB 2021, of a murine antibody, heavy chain 9606
834 5E0Q 1 A Anti-Nup98 Nanobody TP377 30538
835 5CSZ 1 A, H GANTENERUMAB FAB FRAGMENT HEAVY CHAIN FAB 9606
836 5CSZ 2 B, L GANTENERUMAB FAB FRAGMENT LIGHT CHAIN FAB 9606
837 4LHJ 2 B Camelid antibody 30538
838 3WFH 1 A mAb Fab H fragment 10090
839 3WFH 2 B mAb Fab L fragment 10090
840 4BEL 2 D, E XA4813 9844
841 5M7Q 1 A, B Nanobody NbD2 9838
842 5H8D 1 A VHH nanobody 9844
843 3LN9 1 A Immunoglobulin heavy chain antibody variable domain B10 9835
844 5EBG 1 A, B T-cell surface glycoprotein CD8 alpha chain UNP RESIDUES 25-139 9913
845 4K3D 1 H, I BOVINE ANTIBODY WITH ULTRALONG CDR H3, HEAVY CHAIN 9913
846 4K3D 2 L, M BOVINE ANTIBODY WITH ULTRALONG CDR H3, LIGHT CHAIN 9913
847 4H8W 2 H FAB HEAVY CHAIN OF ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ANTIBODY N5-I5 9606
848 4H8W 3 L FAB LIGHT CHAIN OF ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ANTIBODY N5-I5 9606
849 3HNT 1 H CS-35 Fab Heavy Chain Heavy Chain 10090
850 3HNT 2 L CS-35 Fab Light Chain Light Chain 10090
851 5HYF 1 A Ig gamma-1 chain C region Knob protein UNP residues 104-330 9606
852 5IP4 1 A, B XA4551 NANOBODY AGAINST C-DCX 9844
853 3DUR 1 A, C antibody Fv fragment SAG173-04 variable region fragment (Fv) 10090
854 3DUR 2 B, D Ig-like protein 10090
855 1WEJ 1 L E8 ANTIBODY IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB 10090
856 1WEJ 2 H E8 ANTIBODY IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB 10090
857 2APF 1 A T cell receptor beta chain V 10116
858 5VPG 2 C FAB 4C1 - LIGHT CHAIN 10090
859 5VPG 3 D FAB 4C1 - HEAVY CHAIN 10090
860 5HI4 2 C, H CAT-2000 FAB heavy chain 9606
861 5HI4 3 D, L CAT-2000 FAB light chain 9606
862 5NUZ 1 A, H eOD01 heavy chain Fab fragment (domains: variable heavy and constant heavy 1) Fab fragment (domains: variable heavy and constant heavy 1) 10090
863 5NUZ 2 B, L eOD01 light chain Fab fragment (domains: variable light and constant light) Fab fragment (domains: variable light and constant light) 10090
864 5FCU 2 H JR4 FAB HEAVY CHAIN 9544
865 5FCU 3 L JR4 FAB LIGHT CHAIN 9544
866 3RVW 2 C 4C1 - light chain 10090
867 3RVW 3 D 4C1 - heavy chain 10090
868 5DD3 1 H ANTI-HIV ANTIBODY DH570.4 FAB HEAVY CHAIN 9544
869 5DD3 2 L ANTI-HIV ANTIBODY DH570.4 FAB LIGHT CHAIN 9544
870 4C54 1 A, B IG GAMMA-4 CHAIN C REGION FC FRAGMENT, RESIDUES 114-327 9606
871 5XKU 2 B HNIgGA6 light chain 9606
872 5XKU 3 C HNIgGA6 heavy chain 9606
873 4W4N 1 A, B Ig gamma-1 chain C region UNP residues 107-329 9606
874 5T93 1 A, B, C, D ALT-05 immunoglobulin light chain variable domain from light chain amyloidosis patient last residue was not visible on electron density 9606
875 3D85 1 A FAB of antibody 7G10, light chain light chain 9606
876 3D85 2 B FAB of antibody 7G10, heavy chain heavy chain 9606
877 4Z95 1 H S1-15 Fab (IgG2b) heavy chain 10090
878 4Z95 2 L S1-15 Fab (IgG2b) light chain 10090
879 5HI5 2 C, H CAT-2000 FAB heavy chain 9606
880 5HI5 3 D, L CAT-2000 light chain 9606
881 5JO5 1 A, C, E, H 10E8 gHV 9606
882 5JO5 2 B, D, F, L 10E8 gLV 9606
883 5L9D 1 H MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA HEAVY CHAIN 10090
884 5L9D 2 L MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA LIGHT CHAIN 10090
885 2XV6 2 B, D CAMELID VHH 9 30538
886 4QO1 1 A Nb139 Nanobody against the DNA-binding domain of p53 9844
887 5CCK 1 H Antibody 3BC315 Fab heavy chain 9606
888 5CCK 2 L Antibody 3BC315 Fab light chain 9606
889 3VXS 3 D H27-14 TCR alpha chain 9606
890 3VXS 4 E H27-14 TCR beta chain 9606
891 1LVE 1 A LEN, A VARIABLE DOMAIN FROM KAPPA-4 TYPE 9606
892 5I76 1 A, C FM318_light_chain 1383439
893 5I76 2 B, D FM318_heavy_cahin 1383439
894 1KCV 1 L PC282 IMMUNOGLOBULIN light chain 10090
895 1KCV 2 H PC282 IMMUNOGLOBULIN heavy chain 10090
896 1FLR 1 L 4-4-20 (IG*G2A=KAPPA=) FAB FRAGMENT 10090
897 1FLR 2 H 4-4-20 (IG*G2A=KAPPA=) FAB FRAGMENT 10090
898 5I18 1 L FAB LIGHT CHAIN 9606
899 5I18 2 H FAB HEAVY CHAIN 9606
900 4JN1 1 H anti-dabigatran Fab1, heavy chain 10090
901 4JN1 2 L anti-dabigatran Fab1, light chain 10090
902 4ZG1 1 A, B, C, D, E, F NB17 9844
903 4P3D 1 A, H Heavy Chain Fab fragment of antibody LEM-2/15 10090
904 4P3D 2 B, L Light Chain Fab fragment of antibody LEM-2/15 10090
905 4G5Z 1 H canakinumab antibody fragment heavy chain 9606
906 4G5Z 2 L canakinumab antibody fragment light chain 9606
907 2IMM 1 A IGA-KAPPA MCPC603 FV (LIGHT CHAIN) 10090
908 3TNM 1 A, H Fab heavy chain of human anti-HIV-1 Env antibody A32 9606
909 3TNM 2 B, L Fab light chain of human anti-HIV-1 Env antibody A32 9606
910 2OK0 2 L Fab ED10 light chain 10090
911 2OK0 3 H Fab ED10 heavy chain 10090
912 3SOB 1 L antibody light chain 9606
913 3SOB 3 H antibody heavy chain 9606
914 4I1N 2 B Protein ca1697 (nanobody) 9844
915 5AWN 1 H Heavy chain of 3BC176 Fab 9606
916 5AWN 2 L Light chain of 3BC176 Fab 9606
917 4ZFO 2 L J22.9-xi Fab, Light Chain Fab Light Chain fragment of anti-BCMA antibody J22.9-xi 10090
918 4ZFO 3 A, H J22.9-xi Fab, Heavy Chain Fab Heavy Chain fragment of anti-BCMA antibody J22.9-xi 10090
919 4ZFO 4 B J22.9-xi Fab, Light Chain Fab Light Chain fragment of anti-BCMA antibody J22.9-xi 10090
920 4G6M 2 H heavy chain of gevokizumab antibody binding fragment 10090
921 4G6M 3 L light chain of gevokizumab antibody binding fragment 10090
922 5DR5 1 H AbD09097 Fab heavy chain The Fab heavy chain contains a C-terminal Myc- and hexahistidine extension preceded by thrombin peptidase recognition sequence to facilitate detection and purification 9606
923 5DR5 2 L AbD09097 Fab light chain 9606
924 3QXW 1 A, B, C, D, E Anti-Methotrexate CDR1-4 Graft VHH 9844
925 2UV3 1 A, B TYROSINE-PROTEIN PHOSPHATASE NON-RECEPTOR TYPE SUBSTRATE 1 CD47 BINDING DOMAIN, RESIDUES 31-148 9606
926 2IH3 1 A FAB Heavy Chain 10090
927 2IH3 2 B FAB Light Chain